U
Turn Therapeutics Inc. TTRX
$4.85 -$0.39-7.44% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -2.56M -2.16M -1.77M -1.69M -1.61M
Total Depreciation and Amortization 49.40K 48.40K 47.40K 43.50K 39.60K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 671.60K 516.60K 361.60K 177.60K -6.40K
Change in Net Operating Assets 232.80K 115.50K -1.80K 146.50K 294.80K
Cash from Operations -1.60M -1.48M -1.36M -1.32M -1.29M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -83.00K -91.20K -99.40K -89.20K -79.00K
Cash from Investing -83.00K -91.20K -99.40K -89.20K -79.00K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 3.99M 2.57M 1.15M 729.60K 306.80K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 3.99M 2.57M 1.15M 729.60K 306.80K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 2.31M 998.30K -308.40K -683.30K -1.06M